about
Anticoagulation strategies for treatment of ischemic stroke and antiphospholipid syndrome: case report and review of the literature.Addressing competencies for the future in the professional curriculum.A checklist for the development of faculty mentorship programs.Vitamin D supplementation: what's known, what to do, and what's needed.White paper: value of specialty certification in pharmacy.Dosing of unfractionated heparin in acute coronary syndromes.Treatment Approach to Patients With Severe Insulin Resistance.Making residency training an expectation for pharmacists in direct patient care roles.Type 2 diabetes mellitus and heart failure.Developing a business-practice model for pharmacy services in ambulatory settings.The impact of advanced pharmacy practice experiences on students' readiness for self-directed learning.Continuous subcutaneous insulin infusion therapy: A primer on insulin pumps.Improving the quality of care for patients at risk for venous thromboembolism.Best practice strategies for effective use of questions as a teaching tool.Beliefs and behaviors of professionally engaged pharmacists.Impact of a national antimicrobial stewardship mentoring program: Insights and lessons learned.Facilitating the safe use of insulin pens in hospitals through a mentored quality-improvement program.Faculty development: who, what, why, where, when, and how?Improving anticoagulant use for prevention of venous thromboembolism. Introduction.Hypoglycemic effect of bitter melon compared with metformin in newly diagnosed type 2 diabetes patients.Improved Learning Outcomes After Flipping a Therapeutics Module: Results of a Controlled Trial.Improving peer review: What journals can do.Improving peer review: What authors can do.Improving peer review: What reviewers can do.It's Time to Dismantle CE and Build a CPI System.The diabetes epidemic: can we stop the spread?When do patients with Parkinson disease disclose their diagnosis?Emerging treatments for patients with type 2 diabetesCase presentation: a patient with type 2 diabetesChallenges in managing venous thromboembolism and acute coronary syndrome: case studies of the use of antithrombotic and antiplatelet therapies. IntroductionBoard Certification of Pharmacist SpecialistsDevelopment and validation of an instrument to determine patient knowledge: the oral anticoagulation knowledge testASHP Therapeutic Position Statement on the Treatment of HypertensionPrevalence of and factors that influence board certification among pharmacy practice faculty at United States colleges and schools of pharmacyDoes board certification really matter?ACCP Template for Evaluating a Clinical PharmacistImplementation Science to Advance Care Delivery: A Primer for Pharmacists and Other Health ProfessionalsBest practices in ensuring the safe use of insulin pens in the hospital: IntroductionBest practices for safe use of insulin pen devices in hospitals: Recommendations from an expert panel Delphi consensus processValidation of the entrustable professional activities for new pharmacy graduates
P50
Q33372751-629AF4FE-4F7D-4D3B-B5AB-648D65C8A1D7Q33687198-421C00C1-E9A8-40FD-9E60-221029FAC6E5Q33781849-83568C23-43A1-41C2-A14A-7C7CE5D1871DQ34264605-A8496C27-6270-470A-A34B-EC5551297758Q35923898-A1FF553B-B6F5-4697-A75E-04410E2B0D6EQ35976822-337E0D71-DB7A-46C0-AF96-924F30E3C4ABQ36803134-1270F1E2-5188-4D18-8022-A8CE163066F0Q36929428-4EE28069-B150-4242-BED6-EC550717A5C5Q37069176-93D81F45-28D9-4FC6-BF14-E66B5D67C02DQ37069203-E9D41FE0-B584-466D-8AEC-21A2230B1A92Q37287874-97DFFC7B-5E0C-4204-94F5-D06A31BD707FQ37386427-F5B4D991-DC62-4E82-A7FD-C8730AB686B5Q37755891-70A2EAE8-E8C7-41B8-95D1-270567A7257CQ38139918-A1396AEF-423B-420C-998C-4B7768128C54Q38852618-D78B3C4F-0975-43F2-B231-2183840209A7Q39023739-4D4FA5FA-01F0-4D04-BC07-5324E33409A0Q39372742-077A2702-5C4B-47E9-9C77-F20125D09082Q40920624-C3C885D9-4879-44A1-BECC-9FEA97C1CC9CQ44217836-1FB923D3-8A42-4BD6-B88E-306A769BE104Q47329922-230FB8C3-090D-47CF-A490-749B3287BC0CQ47359789-E1C60337-FACE-430B-9C43-C5CF47B92BBAQ50091809-04A824A6-098D-4930-BEE1-508B18557529Q50091815-4E390AA9-CC03-46C1-9A44-D95D51C4928AQ50091820-711A80F7-E897-4A53-B743-C49F0922F658Q55710525-80A270A3-5CAC-4B7F-B9ED-C9DCDC5AF92EQ79240756-1F58805F-6D6B-4FB2-9320-EB6B9C6DB579Q80071464-8435C370-9A9F-4A69-AF96-8FDB27FE234CQ80428651-6527D09B-1061-41D3-80C4-CB944C5D5302Q80428658-CD602872-52FA-437B-9B4E-293A142334CDQ81696910-4D23AB0A-712A-4EF3-9632-8CA27EC419B4Q82191174-3902A464-BCF1-42B5-AA84-36F232B3CF54Q82902608-C43A5C43-C4AE-41DD-A69B-02D717C23F6FQ83367421-A6B20271-C139-455A-BB8A-A38D7F333A40Q85888844-7AC4D07A-A6C8-46E0-A37F-5C29D6875F52Q87546891-E401FDE5-BFE7-4D34-A35B-0A12D38A3FE6Q87851942-18898F72-E309-4A81-AA8E-00EA0CC2D0D7Q88291855-A453957B-EFD2-4A1B-913C-1E83693F57B1Q88365057-8733FAFB-79E2-44D8-9A95-4F7938A221C0Q88365058-726E90F0-B56D-44BD-BDC6-C536F0A986ADQ90926367-CEB144CB-5BF6-4C03-A0E3-9C4ABFBF6D84
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Stuart T Haines
@en
Stuart T Haines
@nl
type
label
Stuart T Haines
@en
Stuart T Haines
@nl
prefLabel
Stuart T Haines
@en
Stuart T Haines
@nl
P31
P496
0000-0001-8217-1871